Danny N. Khalil
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research, Genetic factors in colorectal cancer, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → The future of cancer treatment: immunomodulation, CARs and combination immunotherapy(2016)1,157 cited
- → Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures(2016)1,028 cited
- → Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies(2018)577 cited
- → Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection(2020)220 cited
- → Erratum: The future of cancer treatment: immunomodulation, CARs and combination immunotherapy(2016)190 cited
- → Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer(2021)182 cited
- → Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer(2022)140 cited
- → Immune checkpoint inhibitors for hepatocellular carcinoma(2019)106 cited
- → Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer(2021)84 cited
- → Rational development of combination therapies for biliary tract cancers(2022)68 cited